Accepted for/Published in: JMIR mHealth and uHealth
Date Submitted: Nov 7, 2019
Date Accepted: Mar 23, 2020
Acceptability of text messages for parents for the prevention of child drowning in Bangladesh: Randomized controlled trial
ABSTRACT
Background:
Background:
In many cases, greater use is being made of sending text messages from cell phones as a means of communication between patients and healthcare providers in countries around the world.
Objective:
Objectives: We studied the use of cell phones and the factors related to the acceptability of text messages for parents for the prevention of child drowning in Bangladesh.
Methods:
Methods:
Design: In a randomized controlled trial involving 800 parents (10% of total sample size was 80), socio-economic status, cell phone use, and acceptability to read drowning SMS were measured. Setting: 80 patents were selected from THE rural areas in Rajshahi District, Bangladesh. Participants: Patients who have one child under five years old. Interventions: Cell based SMS. Outcome: Multivariate regression was used to determine the factors related to the acceptability of text messages for parents for the prevention of child drowning in Bangladesh.
Results:
Results:
The acceptability of SMS for the prevention of child drowning in Bangladesh was significantly lower among women (OR = 0.50, 95% CI = 0.12-1.96, p-value=0.020) compared to men; parents older than 30 years (OR = 0.17, 95% CI = 0.14-1.70, p-value=0.01) compared to parents aged below 30 years; and was more acceptable among parents who had an education (OR = 1.63, 95% CI = 1.11-5.80, p-value=0.04) than among illiterate parents; and parents with a household income of over 7000 Bangladeshi Taka (OR = 1.27, 95% CI = 1.06-1.96, p-value=0.05) than among parents whose monthly income was less than 7000 Bangladeshi Taka.
Conclusions:
Conclusion: The high percentage of cell phone use and the acceptability of SMS for parents for the prevention of child drowning are encouraging in terms of identifying the best strategy for using such technologies and deserve further evaluation. Clinical Trial: Trial registration: ISRCTN13774693, 08/03/2015.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.